-
Early in 1992, two women in their 40s were treated for renal failure in a hospital in Brussels, Belgium. Both had been healthy and not recently taking any medications, although one had previously used a beta-agonist asthma inhaler for 8 years.
-
Goal: To assess the effect of Tai Chi Chuan (TCC) training on risk factors for coronary artery disease (CAD) in people with dyslipidemia.
-
Enrollment into the Trial to Assess Chelation Therapy (TACT), a five-year, $30-million National Institutes of Health-funded clinical study, has been stopped, according to Heartwire, a professional news service of WebMD.
-
Moll and colleagues from Amsterdam performed a subgroup analysis within their randomized clinical trial of women with polycystic ovary syndrome comparing metformin plus clomiphene treatment with clomiphene alone.
-
Glinert and colleagues from Israel report the use of photodynamic therapy to successfully ablate single feto-placental implantations in rats.
-
July of this year represented the 5-year anniversary of the publication of Gynecologic Oncology Group (GOG) protocol 178, a pivotal trial demonstrating the significant impact of 9 additional months of paclitaxel chemotherapy to women who had achieved a complete clinical response to primary therapy.
-
In the Issue: Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
Cigarettes and pregnancy are a risky combination, and there is an abundance of data to indicate that perinatal outcome is improved if patients can abstain from smoking.
-
-
Concerns about the effects of the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City; Medroxyprogesterone Acetate Injectable Suspension USP, Teva Pharmaceuticals USA, North Wales, PA) on bone mineral density (BMD) should not prevent clinicians from prescribing the method, nor should its use be limited to two years, according to a new committee opinion released by the American College of Obstetricians and Gynecologists (ACOG).
